[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:cerebral-aneurysm":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":42,"states":43},"Cerebral Aneurysm",5,3,[8,15,21,28,36],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT06693011","Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)",[],"RECRUITING","2026-08-26T02:16:22.235886Z","2026-04-29T02:57:57.156465Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06123325","Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)",[],"2026-08-26T02:15:50.539717Z","2026-05-05T02:43:26.901311Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":26,"content_modified":27},"NCT04141020","Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms",[25],"Phase 2","2026-08-26T02:18:01.700186Z","2026-05-05T02:43:28.877691Z",{"nct_id":29,"title":30,"phases":31,"status":33,"updated_at":34,"content_modified":35},"NCT07246629","Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage",[32],"Phase 4","NOT_YET_RECRUITING","2026-08-26T02:18:04.640417Z","2026-05-05T02:43:29.075942Z",{"nct_id":37,"title":38,"phases":39,"status":33,"updated_at":40,"content_modified":41},"NCT07086183","Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy",[],"2026-08-26T02:16:27.227548Z","2026-05-13T02:55:06.650976Z",[],[]]